Benzinga | May 6, 2021 04:37PM EDT

ZIOPHARM Oncology Q1 EPS $(0.10), Inline

ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 11.11 percent decrease over losses of $(0.09) per share from the same period last year.